This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Poseida Therapeutics, Inc., Transposagen Biopharmaceuticals, Inc.. Active years: 2013-2022.
Company Filing History:

Years Active: 2013-2022
Title: The Innovative Mind of Blair Madison: Pioneering Advances in Genetic Engineering
Introduction: Blair Madison, an accomplished inventor based in Philadelphia, PA, is known for his significant contributions to the field of genetic engineering. With a total of five patents to his name, Madison has become a prominent figure in the biopharmaceutical industry, specifically focusing on advanced transposase proteins.
Latest Patents: One of Madison's notable patents includes the development of hyperactive PiggyBac transposases. This innovation offers a range of PiggyBac transposase proteins, along with nucleic acids that encode these proteins. It also encompasses various compositions and kits containing these elements. Furthermore, his patent outlines methods for using these proteins and describes the creation of non-human transgenic animals that incorporate them, showcasing the potential applications of his work in genetic research and therapy.
Career Highlights: Madison has made a significant impact in the biotechnology sector through his work with various organizations. He has contributed his expertise at Poseida Therapeutics, Inc. and Transposagen Biopharmaceuticals, Inc., where his innovative approach to genetic engineering has driven advancements in therapeutic solutions.
Collaborations: Throughout his career, Blair Madison has teamed up with notable professionals in the field, including his coworker Eric Michael Ostertag. This collaboration has resulted in the creation of pioneering technologies that push the boundaries of genetic manipulation and therapeutic development.
Conclusion: Blair Madison's contributions to the field of genetics through his patents, collaborations, and career highlights illustrate his role as a forward-thinking inventor. His work not only showcases his innovative spirit but also promises to advance the landscape of biopharmaceuticals and genetic engineering for future generations.